Roche CEO Thomas Schinecker Talks Blockbuster Cancer Pill, Earnings

About this episode

Roche CEO Thomas Schinecker discusses the company's earnings and the potential launch of a new breast cancer pill.

Roche CEO Thomas Schinecker joins Bloomberg's "The Opening Trade" to discuss his company's earnings and the timeline for the potential launch for Roche's blockbuster breast cancer pill that may become one of the company's biggest sellers by the end of the year. See omnystudio.com/listener for privacy information.

People in this episode

Host: Bloomberg

Guest: Thomas Schinecker

Topics covered

• cancer treatment
• pharmaceuticals
• earnings report
• business strategy
• healthcare innovation

Keywords

• Roche
• Thomas Schinecker
• cancer pill
• earnings
• breast cancer
• pharmaceuticals
• business news

Mentioned in this episode

Organizations: Roche

Products: blockbuster breast cancer pill

More episodes of Bloomberg Talks

• Former SEC Chair Gary Gensler Talks SpaceX & Mega IPO Risks · June 12, 2026 · 9 min
• Jim Chanos Talks SpaceX IPO · June 12, 2026 · 14 min
• Instant Reaction: SpaceX Jumps in First Trades Following Record $75 Billion IPO · June 12, 2026 · 16 min
• US Energy Secretary Chris Wright Talks Oil Flows Through Strait of Hormuz · June 12, 2026 · 27 min
• Chevron CEO Mike Wirth Talks Middle East Footprint · June 12, 2026 · 16 min
• FC Dallas President & Co-Chair Dan Hunt Talks Hosting FIFA World Cup Games · June 12, 2026 · 11 min